001     292595
005     20241204143044.0
024 7 _ |a 10.1016/j.colsurfb.2024.114187
|2 doi
024 7 _ |a pmid:39243709
|2 pmid
024 7 _ |a 0927-7765
|2 ISSN
024 7 _ |a 1873-4367
|2 ISSN
024 7 _ |a altmetric:166831565
|2 altmetric
037 _ _ |a DKFZ-2024-01825
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Zamborlin, Agata
|b 0
245 _ _ |a Invasiveness modulation of glioma cells by copper complex-loaded nanoarchitectures.
260 _ _ |a [Erscheinungsort nicht ermittelbar]
|c 2025
|b Science Direct
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1733319023_12765
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:E041#
520 _ _ |a Among the tumors with the highest lethality, gliomas are primary brain tumors associated with common recurrence inclined to metastasize along the neuraxis and occasionally out of the central nervous system. Even though metastasis is the main responsible for death in oncological patients, few dedicated treatments are approved. Therefore, the establishment of effective anti-metastasis agents is the final frontier in cancer research. Interestingly, some copper complexes have demonstrated promising efficacy as antimetastatic agents, but they may cause off-site effects such as the alteration of copper homeostasis in healthy tissues. Thus, the incorporation of copper-based antimetastatic agents in rationally designed nano-architectures can increase the treatment localization reducing the side effects. Here, copper complex loaded hybrid nano-architectures (CuLNAs) are presented and employed to assess the impact of an intracellular copper source on glioma cell invasiveness. The novel CuLNAs are fully characterized and exploited for cell migration modulation in a glioma cell line. The results demonstrate that CuLNAs significantly reduce cell migration without impairing cell proliferation compared to standard gold and copper NAs. A concomitant antimigratory-like regulation of the epithelial-to-mesenchymal transition genes confirmed these results, as the gene encoding for the epithelial protein E-cadherin was upregulated and the other explored mesenchymal genes were downregulated. These findings, together with the intrinsic behaviors of NAs, demonstrate that the inclusion of metal complexes in the nano-architectures is a promising approach for the composition of a family of agents with antimetastatic activity.
536 _ _ |a 315 - Bildgebung und Radioonkologie (POF4-315)
|0 G:(DE-HGF)POF4-315
|c POF4-315
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Copper complex
|2 Other
650 _ 7 |a Epithelial-to-mesenchymal transition
|2 Other
650 _ 7 |a Gold nanoparticles
|2 Other
650 _ 7 |a Invasiveness
|2 Other
650 _ 7 |a Metastasis
|2 Other
650 _ 7 |a Neuroglioma
|2 Other
700 1 _ |a Pagliari, Francesca
|0 P:(DE-He78)d06e5bb2d0828caa2be79a51825e84e1
|b 1
|u dkfz
700 1 _ |a Ermini, Maria Laura
|b 2
700 1 _ |a Frusca, Valentina
|b 3
700 1 _ |a García-Calderón, Daniel
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Tirinato, Luca
|0 P:(DE-He78)62f71d68e658453766d3f349b2b718d4
|b 5
700 1 _ |a Volante, Stefania
|b 6
700 1 _ |a Bresciani, Giulio
|b 7
700 1 _ |a Marchetti, Fabio
|b 8
700 1 _ |a Seco, Joao
|0 P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe
|b 9
|e Last author
|u dkfz
700 1 _ |a Voliani, Valerio
|b 10
773 _ _ |a 10.1016/j.colsurfb.2024.114187
|g Vol. 245, p. 114187 -
|0 PERI:(DE-600)1500523-9
|p 114187
|t Colloids and surfaces / B
|v 245
|y 2025
|x 0927-7765
909 C O |p VDB
|o oai:inrepo02.dkfz.de:292595
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)d06e5bb2d0828caa2be79a51825e84e1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)62f71d68e658453766d3f349b2b718d4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-315
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Bildgebung und Radioonkologie
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b COLLOID SURFACE B : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b COLLOID SURFACE B : 2022
|d 2023-10-21
920 2 _ |0 I:(DE-He78)E041-20160331
|k E041
|l Med. Physik in der Radioonkologie
|x 0
920 1 _ |0 I:(DE-He78)E041-20160331
|k E041
|l Med. Physik in der Radioonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E041-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21